Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1985-11-19
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0340-3696
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
504-6
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4051562-Chlorpromazine,
pubmed-meshheading:4051562-Complement C3,
pubmed-meshheading:4051562-Dapsone,
pubmed-meshheading:4051562-Female,
pubmed-meshheading:4051562-Humans,
pubmed-meshheading:4051562-Immunoglobulin A,
pubmed-meshheading:4051562-Middle Aged,
pubmed-meshheading:4051562-Vasculitis
|
pubmed:year |
1985
|
pubmed:articleTitle |
Treatment of vasculitis with chlorpromazine and dapsone.
|
pubmed:publicationType |
Journal Article,
Case Reports
|